BofA/Merrill Lynch Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral

March 4, 2013 7:04 AM EST Send to a Friend
Get Alerts BMY Hot Sheet
Price: $64.89 -1.14%

Rating Summary:
    11 Buy, 8 Hold, 5 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 15 | New: 16
Trade BMY Now!
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Buy to Neutral.

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $37.15 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment